-
1
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
Published 2013-10-01Subjects: Get full text
Article -
2
Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs
Published 2025-01-01Subjects: “…infliximab…”
Get full text
Article -
3
Analysis of the risk of oncological adverse events associated with infliximab in combination with azathioprine compared to monotherapy: insights from the FAERS database
Published 2025-01-01Subjects: “…infliximab…”
Get full text
Article -
4
-
5
Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience
Published 2019-12-01Subjects: Get full text
Article -
6
-
7
Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect?
Published 2024-12-01Subjects: Get full text
Article -
8
Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
Published 2025-01-01Subjects: Get full text
Article -
9
Therapeutic drug monitoring and neutralizing anti-drug antibody detection to optimize TNF-alpha inhibitor treatment for uveitis
Published 2025-01-01Subjects: Get full text
Article -
10
Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
Published 2020-11-01Subjects: Get full text
Article -
11
Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy
Published 2024-01-01Subjects: Get full text
Article